A Survey of Hesitancy and Response to the COVID-19 Vaccine Among Patients With Epilepsy in Northeast China

Objective: This study was conducted to investigate the hesitancy and response of people with epilepsy (PWE) to the coronavirus disease 2019 (COVID-19) vaccine.Methods: We conducted an online survey among PWE in northeast China about hesitancy and response to the COVID-19 vaccine. Their demographic b...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nan Li, Chaojia Chu, Weihong Lin
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	COVID-19 vaccine hesitancy epilepsy side effect China Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/80374f90d40243eba572373f3c268557
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:80374f90d40243eba572373f3c268557
record_format	dspace
spelling	oai:doaj.org-article:80374f90d40243eba572373f3c2685572021-11-17T05:09:57ZA Survey of Hesitancy and Response to the COVID-19 Vaccine Among Patients With Epilepsy in Northeast China1664-229510.3389/fneur.2021.778618https://doaj.org/article/80374f90d40243eba572373f3c2685572021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fneur.2021.778618/fullhttps://doaj.org/toc/1664-2295Objective: This study was conducted to investigate the hesitancy and response of people with epilepsy (PWE) to the coronavirus disease 2019 (COVID-19) vaccine.Methods: We conducted an online survey among PWE in northeast China about hesitancy and response to the COVID-19 vaccine. Their demographic background and symptomatic data about epilepsy were also recorded, and we analyzed the epilepsy-related risk factors in delaying the vaccine.Results: In total, 357 patients with confirmed epilepsy were included in the survey, and only 38 (11%) patients received the COVID-19 vaccine. Fear of aggravating epilepsy (58%, n = 185), discouragement from health workers for epilepsy (22%, n = 70), and fear of patients of other unknown serious side effects (13%, n = 42) were the main reasons for delaying vaccination. A higher seizure frequency was the only epilepsy-related risk factor in delaying the vaccine (OR = 1.104, 95% CI: 0.988–1.233). None of the vaccinated patients reported that the vaccine aggravated their epilepsy.Significance: Understanding concerns about the COVID-19 vaccine among PWE could help to improve health education and promote the establishment of an immune barrier.Nan LiChaojia ChuWeihong LinFrontiers Media S.A.articleCOVID-19vaccine hesitancyepilepsyside effectChinaNeurology. Diseases of the nervous systemRC346-429ENFrontiers in Neurology, Vol 12 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 vaccine hesitancy epilepsy side effect China Neurology. Diseases of the nervous system RC346-429
spellingShingle	COVID-19 vaccine hesitancy epilepsy side effect China Neurology. Diseases of the nervous system RC346-429 Nan Li Chaojia Chu Weihong Lin A Survey of Hesitancy and Response to the COVID-19 Vaccine Among Patients With Epilepsy in Northeast China
description	Objective: This study was conducted to investigate the hesitancy and response of people with epilepsy (PWE) to the coronavirus disease 2019 (COVID-19) vaccine.Methods: We conducted an online survey among PWE in northeast China about hesitancy and response to the COVID-19 vaccine. Their demographic background and symptomatic data about epilepsy were also recorded, and we analyzed the epilepsy-related risk factors in delaying the vaccine.Results: In total, 357 patients with confirmed epilepsy were included in the survey, and only 38 (11%) patients received the COVID-19 vaccine. Fear of aggravating epilepsy (58%, n = 185), discouragement from health workers for epilepsy (22%, n = 70), and fear of patients of other unknown serious side effects (13%, n = 42) were the main reasons for delaying vaccination. A higher seizure frequency was the only epilepsy-related risk factor in delaying the vaccine (OR = 1.104, 95% CI: 0.988–1.233). None of the vaccinated patients reported that the vaccine aggravated their epilepsy.Significance: Understanding concerns about the COVID-19 vaccine among PWE could help to improve health education and promote the establishment of an immune barrier.
format	article
author	Nan Li Chaojia Chu Weihong Lin
author_facet	Nan Li Chaojia Chu Weihong Lin
author_sort	Nan Li
title	A Survey of Hesitancy and Response to the COVID-19 Vaccine Among Patients With Epilepsy in Northeast China
title_short	A Survey of Hesitancy and Response to the COVID-19 Vaccine Among Patients With Epilepsy in Northeast China
title_full	A Survey of Hesitancy and Response to the COVID-19 Vaccine Among Patients With Epilepsy in Northeast China
title_fullStr	A Survey of Hesitancy and Response to the COVID-19 Vaccine Among Patients With Epilepsy in Northeast China
title_full_unstemmed	A Survey of Hesitancy and Response to the COVID-19 Vaccine Among Patients With Epilepsy in Northeast China
title_sort	survey of hesitancy and response to the covid-19 vaccine among patients with epilepsy in northeast china
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/80374f90d40243eba572373f3c268557
work_keys_str_mv	AT nanli asurveyofhesitancyandresponsetothecovid19vaccineamongpatientswithepilepsyinnortheastchina AT chaojiachu asurveyofhesitancyandresponsetothecovid19vaccineamongpatientswithepilepsyinnortheastchina AT weihonglin asurveyofhesitancyandresponsetothecovid19vaccineamongpatientswithepilepsyinnortheastchina AT nanli surveyofhesitancyandresponsetothecovid19vaccineamongpatientswithepilepsyinnortheastchina AT chaojiachu surveyofhesitancyandresponsetothecovid19vaccineamongpatientswithepilepsyinnortheastchina AT weihonglin surveyofhesitancyandresponsetothecovid19vaccineamongpatientswithepilepsyinnortheastchina
_version_	1718425935949070336

A Survey of Hesitancy and Response to the COVID-19 Vaccine Among Patients With Epilepsy in Northeast China

Ejemplares similares